The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $154.19

Today's change+0.15 +0.10%
Updated March 27 11:13 AM EDT. Delayed by at least 15 minutes.
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $154.19

Today's change+0.15 +0.10%
Updated March 27 11:13 AM EDT. Delayed by at least 15 minutes.

Thermo Fisher Scientific Inc up slightly

Thermo Fisher Scientific Inc is up just (U.S.)$0.15 today to (U.S.)$154.19. Shares have lost 1.63% over the last five days, but sit 4.62% below their 52-week high. This security has underperformed the S&P 500 by 3.69% during the last year.

Key company metrics

  • Open(U.S.) $153.44
  • Previous close(U.S.) $154.04
  • High(U.S.) $154.31
  • Low(U.S.) $152.61
  • Bid / Ask(U.S.) $154.18 / (U.S.) $154.24
  • YTD % change+9.28%
  • Volume441,103
  • Average volume (10-day)1,853,777
  • Average volume (1-month)1,489,449
  • Average volume (3-month)1,883,651
  • 52-week range(U.S.) $137.70 to (U.S.) $161.66
  • Beta1.11
  • Trailing P/E30.25×
  • P/E 1 year forward16.81×
  • Forward PEG1.59×
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield0.39%
  • Trailing EPS(U.S.) $5.10
Updated March 27 11:13 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.12%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Oct 01, 201610/01/2016Jul 02, 201607/02/2016Apr 02, 201604/02/2016
Revenue4,9534,4914,5354,295
Total other revenue--------
Total revenue4,9534,4914,5354,295
Gross profit2,2792,0542,0791,958
Total cost of revenue2,6742,4372,4572,337
Total operating expense4,2013,9503,8983,777
Selling / general / administrative1,2571,2121,2191,184
Research & development213183182177
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)571173980
Other operating expenses, total--------
Operating income753541638518
Interest income (expense), net non-operating-131-113-119-106
Gain (loss) on sale of assets--------
Other--------
Income before tax652428521423
Income after tax633474517402
Income tax, total19-46421
Net income630474517402
Total adjustments to net income--------
Net income before extra. items633474517402
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items633474517402
Inc. avail. to common incl. extra. items630474517402
Diluted net income630474517402
Dilution adjustment--------
Diluted weighted average shares397397397399
Diluted EPS excluding extraordinary itemsvalue per share1.591.191.301.01
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share1.981.381.401.20